A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Condition:   Ulcerative Colitis Interventions:   Drug: UTTR1147A;   Drug: UTTR1147A Placebo;   Drug: Vedolizumab;   Drug: Vedolizumab Placebo Sponsor:   Genentech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials